Fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccine development.

Saved in:

Bibliographic Details
Title:	Fully automated high-throughput immuno-µPlaque assay for live-attenuated tetravalent dengue vaccine development.
Authors:	Wang Y; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ, United States., Troutman MC; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ, United States., Hofmann C; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ, United States., Gonzalez A; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ, United States., Song L; Biostatistics, Merck & Co., Inc., Rahway, NJ, United States., Levin R; Vaccine Drug Product Development, Merck & Co., Inc, Rahway, NJ, United States., Pixley HY; Vaccine Drug Product Development, Merck & Co., Inc, Rahway, NJ, United States., Kearns K; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ, United States., DePhillips P; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ, United States., Loughney JW; Analytical Research & Development, Merck & Co., Inc., Rahway, NJ, United States.
Source:	Frontiers in immunology [Front Immunol] 2024 Feb 12; Vol. 15, pp. 1356600. Date of Electronic Publication: 2024 Feb 12 (Print Publication: 2024).
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1664-3224
DOI:	10.3389/fimmu.2024.1356600